Mattheus A, Heise H, Hofmann R
Andrologia. 1980 Jan-Feb;12(1):43-8.
The effect of different Solcoseryl (Solco, Basel, Switzerland) concentrations on the motility of human sperm were tested on 37 ejaculates taken from two subject groups. Altogether 111 motility studies were performed using the eosine vitality test. In view of the considerable variations associated with motility tests, Solcoseryl appeared to have no effect on sperm motility in the majority of cases in group 1. The observed improvement in motility (20%) was countered by still greater motility losses (27%). The results, obtained by studies on selected asthenospermia (group 2) are different, however: the 26% increase in motility was opposed to a motility loss of only 17%. A Solcoseryl concentration of 50% was found to have the best effects on motility. A general rise in sperm motility by means of Solcoseryl cannot be considered, although tests would appear advisable in isolated instances. Solcoseryl may be a valuable protective resuspension agent for insemination purposes.
在取自两个受试者组的37份射精样本上，测试了不同浓度的舒康博（瑞士巴塞尔索尔科公司生产）对人类精子活力的影响。使用伊红活力试验共进行了111次活力研究。鉴于活力测试存在相当大的差异，在第1组的大多数情况下，舒康博似乎对精子活力没有影响。观察到的活力提高（20%）被更大的活力损失（27%）所抵消。然而，对选定的弱精子症患者（第2组）进行研究得到的结果有所不同：活力提高了26%，而活力损失仅为17%。发现50%的舒康博浓度对活力具有最佳效果。虽然在个别情况下进行测试似乎是可取的，但不能认为通过舒康博能使精子活力普遍提高。舒康博可能是一种用于授精目的的有价值的保护性重悬剂。
